CAS: 1269440-54-1 - 4-[3-Iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinamine
Fórmula:C10H12IN5
InChI:InChI=1S/C10H12IN5/c1-6(2)16-5-7(9(11)15-16)8-3-4-13-10(12)14-8/h3-6H,1-2H3,(H2,12,13,14)
Chave InChI:InChIKey=KWNDFHCAHOPJIT-UHFFFAOYSA-N
SMILES:IC1=NN(C=C1C=2N=C(N=CC2)N)C(C)C
- Sinónimos:
- 4-[3-Iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinamine
- 2-Pyrimidinamine, 4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 2-Pyrimidinamine, 4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]- REF: IN-DA000WGACAS: 1269440-54-1 | - - - | A consultar | Qui 02 Jan 25 |
 | Encorafenib Impurity 2 REF: 4Z-E-183005CAS: 1269440-54-1 | - - - | A consultar | Ter 07 Jan 25 |
![2-Pyrimidinamine, 4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-](https://static.cymitquimica.com/products/IN/thumb/DA000WGA.jpg)
2-Pyrimidinamine, 4-[3-iodo-1-(1-methylethyl)-1H-pyrazol-4-yl]-
CAS:1269440-54-1
Fórmula:
C10H12IN5
Peso molecular:
329.1402
Ref: IN-DA000WGA
| Tamanho indefinido | A consultar |
Entrega estimada em Estados Unidos, Quinta-feira 2 de Janeiro de 2025
Ref: 4Z-E-183005
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
